trending Market Intelligence /marketintelligence/en/news-insights/trending/1teZv6xCdrF_v6uN7Aqsqg2 content esgSubNav
In This List

Albireo Pharma plans $50M offering

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Albireo Pharma plans $50M offering

Albireo Pharma, Inc. said it plans to sell common stock having an aggregate offering price of up to $50 million.

Cowen and Co. LLC will act as the company's sales agent.